newsfilter
← Latest News
GlobeNewswire·

Zogenix to Participate in the Raymond James Institutional Investors Conference

EMERYVILLE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that Michael...